Skip to main content
. 2012 Jul 23;7(7):e41675. doi: 10.1371/journal.pone.0041675

Table 2. Cardiovascular risk factors associated with SCD in a multivariate model in four population-based cohorts.

Population cohorts, HR (95% CI) Fixed-effects meta-analysis
FINRISK 1992 FINRISK 1997 FINRISK 2002 Health 2000 I2 HR (95% CI) P-value
Sex, male 3.37 (2.24–5.07) 2.34 (1.56–3.52) 3.12 (1.70–5.74) 2.59 (1.62–4.13) 0.00 2.79 (2.23–3.51) <2.2×10−16
Geographic region, East 1.43 (1.05–1.95) 1.06 (0.78–1.44) 1.60 (0.92–2.79) 1.19 (0.80–1.76) 0.00 1.26 (1.05–1.51) 0.01
HDL/TC ratio 1.22 (0.11–13.4) 0.08 (0.01–1.08) 0.93 (0.04–23.6) 1.27 (0.08–21.1) 0.00 0.56 (0.15–2.16) 0.40
Systolic BP per 10 mmHg 1.17 (1.08–1.26) 1.06 (0.98–1.13) 1.12 (1.02–1.24) 1.06 (0.97–1.16) 0.35 1.10 (1.06–1.15) 4.8×10−6
Prevalent diabetes 2.26 (1.49–3.44) 1.59 (1.07–2.39) 1.57 (0.85–2.88) 1.49 (0.94–2.37) 0.00 1.74 (1.38–2.18) 2.2×10−6
BMI per kg/m2 1.05 (1.02–1.09) 1.01 (0.97–1.04) 1.04 (0.99–1.09) 0.97 (0.92–1.01) 0.71* 1.02 (0.98–1.06) 0.38
Current smoker 2.70 (1.85–3.94) 2.78 (1.89–4.09) 5.48 (3.04–9.86) 4.83 (2.84–8.22) 0.55* 3.55 (2.52–5.00) 3.9×10−13
Former smoker 1.21 (0.79–1.84) 1.28 (0.86–1.90) 1.08 (0.56–2.09) 2.36 (1.38–4.02) 0.39 1.39 (1.10–1.76) 0.007
Physical activity 0.56 (0.41–0.78) 0.58 (0.42–0.80) 0.42 (0.26–0.66) 0.45 (0.31–0.65) 0.00 0.51 (0.43–0.62) 6.7×10−13
Prevalent CHD 4.77 (3.20–7.13) 2.70 (1.77–4.11) 3.56 (2.06–6.17) 5.10 (3.38–7.72) 0.47 3.99 (3.20–4.96) <2.2×10−16
QT-prolonging drug NA 0.76 (0.40–1.42) 1.29 (0.58–2.84) 0.85 (0.46–1.55) 0.00 0.90 (0.61–1.31) 0.57
Digoxin NA 3.33 (1.98–5.60) 2.12 (0.75–6.01) 2.68 (1.41–5.08) 0.00 2.91 (2.00–4.24) 2.7×10−8

BMI  =  body mass index, BP  =  blood pressure, CHD  =  coronary heart disease, CI  =  confidence interval, HDL  =  high-density lipoprotein cholesterol, HR  =  hazard ratio (in Cox regression), I2  =  measure of heterogeneity between studies, SCD  =  sudden cardiac death, TC  =  total cholesterol.

*

Random-effects meta-analysis was used because of significant heterogeneity between studies.

Leisure-time physical activity (moderate/high vs. low).